Analyst Raghuram Selvaraju of Rodman & Renshaw is bullish on both Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Synergy Pharmaceuticals Inc (NASDAQ:SGYP), though for …
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company pioneering the development of uroguanylin analogs as potential new treatments for functional gastrointestinal (GI) disorders and …
Healthcare analysts weigh in today on biotech companies Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Mast Therapeutics Inc (NYSEMKT:MSTX). The analysts positively viewed SGYP’s Plecanatide NDA submission, …
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced the company has filed with the U.S.
Healthcare analysts are out with commentary on biotech stocks Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and ZIOPHARM Oncology Inc. (NASDAQ:ZIOP).
Apple Inc. (NASDAQ:AAPL) is up over 1% in pre-market trading after analyst Abhey Lamba of Mizuho Securities upgraded the stock from Neutral to …
Analysts are weighing in today on biotech company MannKind Corporation (NASDAQ:MNKD) and NY-based drug company Synergy Pharmaceuticals Inc (NASDAQ:SGYP). Here’s a quick roundup of today’s brokerage notes on MNKD …
Analysts weigh in with a few insights on biopharmaceutical companies Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) and Zogenix, Inc.
Analysts are weighing in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX), NY-based drug company Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and NV-based pharma company …
Analysts came out today with an optimistic view on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Relypsa Inc (NASDAQ:RLYP), and Incyte Corporation (NASDAQ:INCY), as the iShares …
